Contemporary cardiac issues in Duchenne muscular dystrophy. Working Group of the National Heart, Lung, and Blood Institute in collaboration with Parent Project Muscular Dystrophy

Circulation. 2015 May 5;131(18):1590-8. doi: 10.1161/CIRCULATIONAHA.114.015151.
No abstract available

Keywords: cardiomyopathy; dystrophin; heart failure; magnetic resonance imaging; muscular dystrophy.

Publication types

  • Practice Guideline

MeSH terms

  • Angiotensin-Converting Enzyme Inhibitors / therapeutic use
  • Animals
  • Arrhythmias, Cardiac / drug therapy
  • Arrhythmias, Cardiac / etiology
  • Biological Specimen Banks / organization & administration
  • Cardiomyopathy, Dilated / drug therapy
  • Cardiomyopathy, Dilated / etiology*
  • Cardiomyopathy, Dilated / therapy
  • Clinical Trials as Topic
  • Combined Modality Therapy
  • Diagnostic Techniques, Cardiovascular
  • Disease Models, Animal
  • Genotype
  • Glucocorticoids / therapeutic use
  • Heart-Assist Devices
  • Humans
  • Male
  • Muscular Dystrophy, Duchenne / complications*
  • Muscular Dystrophy, Duchenne / genetics
  • Phenotype
  • Registries
  • Respiration Disorders / etiology
  • Respiration Disorders / therapy
  • Respiration, Artificial
  • Ventricular Dysfunction, Left / drug therapy
  • Ventricular Dysfunction, Left / etiology
  • Ventricular Dysfunction, Left / therapy

Substances

  • Angiotensin-Converting Enzyme Inhibitors
  • Glucocorticoids